Sheel Biotech Limited Link 
Allotment
The Sheel Biotech IPO will open for subscription on September 30, 2025, and close on October 3, 2025. The IPO is a fixed price issue through which the company plans to raise approximately ₹34.02 crore. The issue consists of a fresh issue aggregating to ₹34.02 crore along with an offer for sale of up to [●] equity shares, each having a face value of ₹10.
The price band for the Sheel Biotech IPO has been set in the range of ₹59 to ₹63 per share. The issue allocation is structured with 50% reserved for Qualified Institutional Buyers (QIBs), 35% for retail investors, and 15% for High Net-worth Individuals (HNIs).
The basis of allotment is expected to be finalized on October 6, 2025, and the company’s equity shares are scheduled to be listed on the NSE on October 8, 2025.
On the financial front, Sheel Biotech reported revenue of ₹102.27 crore in FY2025, up from ₹92.55 crore in FY2024. Net profit stood at ₹10.64 crore in FY2025, compared to ₹10.51 crore in the previous year. Based on the company’s steady financial performance, the IPO appears suitable for investors with a long-term investment perspective.
₹63
0%
Open
₹63
HIgh - Low
₹63
Previous Close
₹63
Total Traded Value
0
52 Weeks High
₹63
52 Weeks Low
₹63
Updates On
Sep 24, 2025
IPO. Open
Sep 30, 2026
IPO. Close
Oct 3, 2026
IPO. Price
₹63.00
IPO Market price
₹128.22 Cr
IPO Details
| IPO Date | 8 Oct |
| IPO Listing Date | 8 Oct |
| IPO Face Value | ₹10 per share |
| IPO Price Range | ₹63.00 |
| IPO Issue Size | 54,00,000 shares |
| IPO Sale Type | Fresh Capital |
| Employee Discount | - |
| IPO Issue Type | 100 % Book Building |
| IPO Listing | NSE SME Platform |
| hare Holding Pre Issue | 1,49,52,550 shares |
IPO Timeline
| IPO Open Date | 30 Sep |
| IPO Close Date | 3 Oct |
| IPO Allotment (Tentative) | 6 Oct |
| Refunds | 7 Oct |
| Credit to Demat Account | 7 Oct |
| IPO Listing Date | 8 Oct |
IPO Reservation
| Category | Offer |
|---|---|
| QIB Shares Offered | 25,50,000 |
| NII (HNI) Shares Offered | 7,74,000 Shares |
| Retail Shares Offered | 18,04,000 Shares |
IPO Lot Size
Investors can bid for a minimum of 4,000 shares, with additional shares available in multiples of 2,000.
| Application | Lots | Share | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 4,000 | ₹2,52,000 |
| Retail (Max) | 2 | 4,000 | ₹2,52,000 |
| S-HNI (Min) | 3 | 6,000 | ₹3,78,000 |
| S-HNI (Max) | 7 | 14,000 | ₹8,82,000 |
| B-HNI (Min) | 8 | 16,000 | ₹10,08,000 |
Incorporated in November 1991, Sheel Biotech Limited operates in the fields of biotechnology, floriculture, greenhouse solutions, and organic farming. The company is engaged in the cultivation and supply of a wide range of plants for field crops, fruits, vegetables, and ornamental flowers, using advanced tissue culture techniques and organic farming practices.
Sheel Biotech also designs, manufactures, and maintains greenhouses, while offering end-to-end farmer support services, including training and capacity building through Farmer-Producer Organizations (FPOs). In addition, the company provides landscaping services to both government bodies and private sector clients.
The company is supported by experienced and skilled promoters, which has played a key role in its steady growth and operational stability. Between the financial years ended March 31, 2024 and March 31, 2025, Sheel Biotech recorded an 11% growth in revenue and a 2% increase in profit after tax (PAT).
Sheel Biotech holds ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications, demonstrating its strong focus on quality management, environmental sustainability, and workplace safety. Its Research and Development laboratory is recognized by the Department of Biotechnology (DBT) and the Department of Science and Technology (DST), Government of India, highlighting its technical capabilities and innovation-driven approach.
Competitive Strengths
* Strong expertise in biotechnology, tissue culture, organic farming, and greenhouse management
* Diversified product and service offerings across agriculture, floriculture, and horticulture
* Emphasis on eco-friendly, sustainable, and organic farming practices
* Integrated services covering plant cultivation, greenhouse solutions, farmer training, and landscaping
Company Financials (Consolidated)
| Assets | 113.28 | 105.95 | 93.89 |
| Total Income | 102.27 | 92.55 | 80.19 |
| Profit After Tax | 10.64 | 10.47 | 5.08 |
| EBITDA | 14.97 | 14.45 | 8.83 |
| NET Worth | 83.85 | 72.69 | 63.54 |
| Reserves and Surplus | 68.9 | 68.58 | 59.4 |
| Total Borrowing | 17.36 | 23.54 | 19.17 |
Key Performance Indicator (KPI
| ROE | 13.59% |
| ROCE | 16.34% |
| Debt/Equity | 0.21 |
| RoNW | 13.59% |
| PAT Margin | 10.45% |
| EBITDA Margin | 14.71% |
| Price to Book Value | 1.11 |
IPO Objects of the Issue
| S.No. | Objects of the ipo Resources Detail | IPO Amount |
|---|---|---|
| 1 | Funding capital expenditure requirements for the purchase of equipment/machineries | 9.12 |
| 2 | To meet out the expenses of Working Capital Requirement | 15.88 |
| 3 | To meet out the General Corporate Purposes; | 4.77 |
| 4 | Offer for Sale (OFS) | - |
Contact Details
Sheel Biotech Ltd.
8 Balaji Estates
, 2nd Floor, Block-C, Guru Ravidas Marg
Kalkaji
South Delhi, New Delhi, 110019
Phone: +91 88511 – 8980
Email: compliance@sheelbiotech.com
Website: http://www.sheelbiotech.com/
Detail Registrar
IPO Registrar
Skyline Financial Services Pvt. Ltd.
Phone: 02228511022
Email: compliances@skylinerta.com
Website: https://www.skylinerta.com/ipo.php
The Sheel Biotech Limited IPO opened for subscription on September 30, 2025, and closed on October 3, 2025. The shares were scheduled for listing on NSE SME on October 8, 2025.
The IPO was priced at ₹63 per share with a face value of ₹10. The total fresh issue comprised 54,00,000 shares, aggregating up to approximately ₹34 crore.
Retail investors were required to apply for a minimum of 4,000 equity shares, equivalent to 2 lots. Applications could be made in multiples of 2,000 shares thereafter.
The issue was allocated with 50% reserved for Qualified Institutional Buyers (QIBs), 35% for retail investors, and 15% for High Net-worth Individuals (HNIs).
For FY2025, the company reported revenue of ₹102.27 crore and PAT of ₹10.64 crore. EBITDA stood at ₹14.97 crore, reflecting steady growth compared to FY2024.
The IPO proceeds were planned for capital expenditure of ₹9.12 crore, working capital needs of ₹15.88 crore, general corporate purposes, and issue-related expenses.
Sheel Biotech Limited shares were listed on the NSE SME platform, providing investors an opportunity to trade shares in the SME segment after listing.
Compare:
